Jeong Heo

Palo Alto University — United States

Medicine · Health Sciences

47h-index10.0kcitations363works16.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Hepatitis C virus research(130), Hepatitis B Virus Studies(102), Liver Disease Diagnosis and Treatment(100), Hepatocellular Carcinoma Treatment and Prognosis(67), Virus-based gene therapy research(40)

Publications358 total

Elebsiran and PEG-IFNα for chronic hepatitis B infection: a partially randomized, open-label, phase 2 trial
Nature Medicine·2025· 2 citedOpen Access
Alopecia areata: from immunopathogenesis to emerging therapeutic approaches
Frontiers in Immunology·2025Open Access
The investigation of selective sphingosine-1 phosphate receptor 1&4 modulator to treat alopecia areata mouse model 2881
The Journal of Immunology·2025Open Access
Beneficial effects of Gryllus bimaculatus extract on muscle atrophy in dexamethasone- stimulated C2C12 Cells
Phytochemistry Letters·2025
SAT-707 Lean Mass Loss after Dietary Weight Loss: A Secondary Analysis of the DIETFITS Randomized Clinical Trial
Journal of the Endocrine Society·2025Open Access
Cancer Vaccines in Hepatocellular Carcinoma: Advances, Challenges, and Future Perspectives
Convergence Hepatology·2025Open Access
Liver Stiffness Measurements After Oral Antivirals Effectively Predict the Risk of HCC in Patients With Chronic Hepatitis C
Journal of Gastroenterology and Hepatology·2025· 2 citedOpen Access
Outcomes by transarterial chemoembolization (TACE) modality from participants (pts) with embolization-eligible hepatocellular carcinoma (HCC) treated with durvalumab (D)+bevacizumab (B)+TACE and placebos (PBO)+TACE: EMERALD-1 subgroup analysis
Zeitschrift für Gastroenterologie·2025
Strategic Structural Modification of Quinoxaline-Based D–A-Type Polymers via Tuning Electron-Withdrawing Substituents for Photovoltaic Applications
ACS Applied Materials & Interfaces·2025· 1 cited
The Effect of Perceived Helpfulness of Community Child Center Services on Children’s Self-Esteem: Focusing on the Mediating Role of Satisfaction with Childcare Teachers
Journal of the Korean society of child welfare·2025
Lactic Acid Bacteria as Probiotics Improve Bioactive Compounds in Radix Angelica gigas (Danggui) via Solid-State Fermentation
Fermentation·2025· 1 citedOpen Access
Risk of HBV reactivation in HBV/HCV-co-infected HCV-treated patients: A single-center study
PLoS ONE·2025Open Access
Outcomes by baseline tumor burden using the 6-and-12 score in EMERALD-1: A phase 3 study of durvalumab (D) ± bevacizumab (B) with transarterial chemoembolization (TACE) in embolization-eligible unresectable hepatocellular carcinoma (uHCC).
Journal of Clinical Oncology·2025
A first-in-human study of MT-303, an innovative in vivo mRNA chimeric antigen receptor (CAR) therapy targeting GPC3, in adults with hepatocellular carcinoma.
Journal of Clinical Oncology·2025· 3 cited
Risk of psychiatric disorders in patients with graves' disease: a nationwide population-based analysis
Endocrine Abstracts·2025
The comparative study of Stretta radiofrequency and anti-reflux mucosectomy in the management of intractable gastroesophageal reflux disease: a single-center retrospective study from Korea
Clinical Endoscopy·2025· 4 citedOpen Access
399: OUTCOMES BY KEY PROGNOSTIC FACTORS IN EMERALD-1: A PHASE 3 STUDY OF DURVALUMAB ± BEVACIZUMAB WITH TRANSARTERIAL CHEMOEMBOLIZATION (TACE) IN PARTICIPANTS WITH EMBOLIZATIONELIGIBLE UNRESECTABLE HEPATOCELLULAR CARCINOMA (UHCC)
Gastroenterology·2025
THU-253 IM-PROVE I: Rapid loss followed by transient increases in HBV RNA in chronic hepatitis B subjects during treatment with imdusiran and pegylated interferon alfa-2a is associated with HBsAg seroclearance
Journal of Hepatology·2025· 1 cited
GS-010 Outcomes of 48 weeks of therapy and subsequent 24-week post-treatment period with tobevibart (VIR-3434) and elebsiran (VIR-2218) with or without pegylated interferon alfa-2a in chronic hepatitis B virus infection. Findings from the MARCH study
Journal of Hepatology·2025· 4 cited
Bepirovirsen for the treatment of chronic hepatitis B infection
Future Virology·2025· 1 cited
page 1 of 18Next →

Frequent Co-authors

Won Young Tak(15), Mong Cho(11), Dae Hwan Kang(11), Geun Am Song(11), Gwang Ha Kim(10), Masatoshi Kudo(9), Hyun Young Woo(7), Man‐Fung Yuen(6), Hyung Joon Yim(6), Jung‐Hwan Yoon(6), Shukui Qin(5), Ann‐Lii Cheng(5), Caroline J. Breitbach(5), David H. Kirn(5), Soo Young Park(5), Young Oh Kweon(5), Do Young Kim(5), Kwang‐Hyub Han(4), Thomas Decaens(4), Riccardo Lencioni(4)